Minimally Invasive Surgical Devices Market Size, Share, Growth and Industry Analysis, By Types (Endoscopes, Laparoscopy Access Instruments, Laparoscopy Handheld Instruments, Robotic Assisted Surgical Systems, Electrosurgery, Visualization and Monitoring System), By Applications (Hospitals, Surgical Centers, Others), Regional Insights and Forecast to 2034

Minimally Invasive Surgical Devices Market Size

As per Global Growth Insights, the Global Minimally Invasive Surgical Devices Market was valued at USD 19.59 Billion in 2024 and is projected to reach USD 20.9 Billion in 2025 and USD 22.29 Billion in 2026, eventually expanding to USD 37.3 Billion by 2034. The market is expected to grow at a healthy CAGR of 6.65% during the forecast period from 2025 to 2034. Growth is driven by the rising preference for less invasive surgical procedures, technological advancements in robotic-assisted and laparoscopic systems, and the increasing focus on reducing patient recovery time and hospital stays. Currently, over 65% of patients worldwide favor minimally invasive procedures due to lower risks and faster rehabilitation, while nearly 55% of hospitals are actively investing in robotic and image-guided surgical technologies. The combination of precision-driven instruments, enhanced visualization, and integration of AI-enabled surgical platforms continues to redefine the future of minimally invasive surgery, improving outcomes and expanding access to advanced medical care globally.

The US Minimally Invasive Surgical Devices Market is witnessing robust growth with over 68% of hospitals adopting robotic-assisted systems and 60% of surgical centers investing in laparoscopic devices. Around 72% of patients in the country prefer minimally invasive techniques due to faster recovery and reduced complications, strengthening its market dominance.

Key Findings

• Market Size: Valued at USD 19.59 Billion in 2024, projected to touch USD 20.9 Billion in 2025 and USD 37.3 Billion by 2034 at a CAGR of 6.65%.
• Growth Drivers: Over 65% of patients prefer non-invasive surgeries, while 58% of hospitals report higher efficiency with advanced surgical devices.
• Trends: Nearly 55% of hospitals are adopting robotic platforms, and 48% of surgical centers are upgrading visualization and monitoring systems.
• Key Players: Medtronic, Intuitive Surgical, Olympus, Stryker, Becton Dickinson & more.
• Regional Insights: North America holds 35% with strong robotic adoption, Europe captures 25% through laparoscopic demand, Asia-Pacific leads 30% driven by patient preference, Middle East & Africa contributes 10% with rising hospital investments.
• Challenges: Around 42% of smaller facilities face adoption barriers, and 38% cite high device costs limiting wider accessibility.
• Industry Impact: Nearly 60% of surgical centers improved patient recovery times, and 50% reported reduced hospital stay duration with device adoption.
• Recent Developments: Over 40% of companies launched robotic upgrades, and 35% introduced enhanced visualization systems in 2024 for better precision.

The minimally invasive surgical devices market is evolving with rapid integration of AI, robotics, and high-definition visualization systems. Around 70% of global healthcare facilities are focusing on upgrading surgical infrastructure, while 50% of device manufacturers are prioritizing innovative handheld and electrosurgical instruments to meet growing demand worldwide.

Minimally Invasive Surgical Devices Market Trends

The minimally invasive surgical devices market is witnessing strong adoption driven by the rising preference for procedures with reduced recovery time. Over 65% of global surgical procedures now incorporate minimally invasive techniques, reflecting a major shift in medical practices. Laparoscopic devices contribute to more than 40% of usage due to their effectiveness in abdominal and gynecological surgeries. Robotic-assisted surgical devices hold around 25% market penetration, with increasing adoption in urology and orthopedic procedures. Additionally, 55% of hospitals worldwide are prioritizing minimally invasive equipment investments to improve patient safety and outcomes. With nearly 70% of patients preferring minimally invasive procedures over conventional surgeries, demand continues to accelerate across healthcare facilities.

Minimally Invasive Surgical Devices Market Dynamics

OPPORTUNITY

Growing preference for outpatient procedures

Over 60% of patients now opt for outpatient minimally invasive surgeries due to shorter hospital stays. Around 50% of surgical centers report a rise in outpatient adoption, while 45% of healthcare systems highlight cost savings and efficiency improvements.

DRIVERS

Rising demand for robotic-assisted surgeries

Robotic surgical systems are expanding rapidly with over 35% penetration in complex procedures. Nearly 55% of surgeons report improved precision, while 40% of hospitals confirm reduced surgical errors and enhanced patient recovery rates.

RESTRAINTS

"High device costs limiting adoption"

Nearly 48% of smaller healthcare facilities struggle to adopt minimally invasive devices due to high equipment costs. Around 42% of clinics report delayed upgrades in surgical infrastructure, while 38% cite budget limitations as a barrier to advanced technology adoption.

CHALLENGE

"Shortage of skilled professionals"

Over 50% of hospitals report a lack of adequately trained surgeons to operate advanced minimally invasive devices. Approximately 37% of healthcare systems face delays in surgeries due to training gaps, and 30% struggle with limited workforce expertise in robotic-assisted procedures.

Segmentation Analysis

The global minimally invasive surgical devices market was USD 19.59 Billion in 2024 and is projected to reach USD 20.9 Billion in 2025, before expanding to USD 37.3 Billion by 2034, registering a CAGR of 6.65% during the forecast period. Segmentation by type reveals that Endoscopes, Laparoscopy Access Instruments, Laparoscopy Handheld Instruments, Robotic Assisted Surgical Systems, Electrosurgery, and Visualization & Monitoring Systems play a pivotal role in shaping the market outlook. Each type holds distinct market shares and growth trajectories with significant contributions from major countries worldwide.

By Type

Endoscopes

Endoscopes dominate minimally invasive procedures due to their extensive use in diagnostics and treatment. Around 45% of procedures globally rely on endoscopic devices, supported by advancements in flexible and capsule endoscopy technologies. High patient preference for endoscopy is boosting demand across hospitals and outpatient facilities.

Endoscopes held a strong position in the market, accounting for USD 5.1 Billion in 2025, representing 24.4% of the total market. This segment is projected to grow at a CAGR of 6.9% from 2025 to 2034, driven by demand in gastroenterology, pulmonology, and oncology.

Top 3 Major Dominant Countries in the Endoscopes Segment

• United States led the Endoscopes segment with a market size of USD 1.6 Billion in 2025, holding a 31% share, driven by advanced healthcare infrastructure and high adoption rates.
• Germany accounted for USD 1.1 Billion in 2025 with a 21% share, supported by technological innovation and strong hospital networks.
• Japan reached USD 0.9 Billion in 2025 with an 18% share, expanding due to strong demand for GI and respiratory endoscopy procedures.

Laparoscopy Access Instruments

Laparoscopy access instruments are vital for abdominal surgeries, ensuring precise entry and reduced patient trauma. More than 35% of laparoscopic procedures globally depend on access systems, highlighting their indispensable role in minimally invasive surgeries.

Laparoscopy Access Instruments captured USD 3.2 Billion in 2025, representing 15.3% of the total market, and are anticipated to grow at a CAGR of 6.3% from 2025 to 2034, driven by demand for gynecological and bariatric surgeries.

Top 3 Major Dominant Countries in the Laparoscopy Access Instruments Segment

• United States led with USD 1.0 Billion in 2025, holding 31% share, supported by bariatric and oncology procedures.
• China recorded USD 0.8 Billion in 2025, capturing 25% share, fueled by rising laparoscopic surgery adoption.
• India accounted for USD 0.6 Billion in 2025 with 19% share, driven by improved surgical infrastructure and rising healthcare access.

Laparoscopy Handheld Instruments

Laparoscopy handheld instruments such as forceps, scissors, and dissectors are widely adopted, representing nearly 40% of laparoscopic tool usage. Their ergonomic design and improved precision contribute significantly to efficiency in surgeries.

Laparoscopy Handheld Instruments held USD 3.7 Billion in 2025, comprising 17.7% of the market. The segment is expected to expand at a CAGR of 6.8% from 2025 to 2034, driven by technological advancements and broader surgical applications.

Top 3 Major Dominant Countries in the Laparoscopy Handheld Instruments Segment

• United States led with USD 1.2 Billion in 2025, holding a 32% share, due to strong adoption in general surgery.
• Japan reached USD 0.9 Billion in 2025, with 24% share, supported by advanced surgical training programs.
• China registered USD 0.8 Billion in 2025, securing 22% share, fueled by rising patient demand for laparoscopic procedures.

Robotic Assisted Surgical Systems

Robotic-assisted systems are transforming minimally invasive surgery, with around 30% of hospitals now integrating robotic technologies. Their precision and efficiency enhance patient safety and outcomes, making them a fast-growing segment.

Robotic Assisted Surgical Systems captured USD 4.5 Billion in 2025, accounting for 21.5% of the global market. This segment is forecasted to grow at a CAGR of 8.2% from 2025 to 2034, fueled by demand in urology, gynecology, and orthopedics.

Top 3 Major Dominant Countries in the Robotic Assisted Surgical Systems Segment

• United States led with USD 2.0 Billion in 2025, holding 44% share, driven by extensive robotic infrastructure.
• South Korea accounted for USD 0.9 Billion in 2025, representing 20% share, supported by high-tech adoption.
• Germany captured USD 0.7 Billion in 2025, securing 15% share, due to strong robotic technology investment.

Electrosurgery

Electrosurgery devices are critical in tissue cutting and coagulation, used in nearly 50% of minimally invasive procedures worldwide. Their reliability and efficiency contribute to strong clinical outcomes in various surgical disciplines.

Electrosurgery held USD 2.8 Billion in 2025, representing 13.4% of the total market. The segment is projected to grow at a CAGR of 5.9% from 2025 to 2034, driven by rising adoption in general and gynecological surgeries.

Top 3 Major Dominant Countries in the Electrosurgery Segment

• United States led with USD 0.9 Billion in 2025, holding 32% share, supported by widespread adoption in hospitals.
• India recorded USD 0.7 Billion in 2025, capturing 25% share, due to growing demand for cost-effective devices.
• Brazil accounted for USD 0.5 Billion in 2025, representing 18% share, with increased use in gynecology and oncology.

Visualization and Monitoring System

Visualization and monitoring systems ensure accuracy and efficiency in surgical procedures, with nearly 55% of surgeons confirming improved outcomes when advanced visualization technologies are used. This segment supports integration with robotics and laparoscopy.

Visualization and Monitoring Systems were valued at USD 1.6 Billion in 2025, representing 7.7% of the global market. The segment is expected to expand at a CAGR of 6.1% from 2025 to 2034, driven by demand for high-definition imaging and real-time monitoring.

Top 3 Major Dominant Countries in the Visualization and Monitoring System Segment

• United States held USD 0.6 Billion in 2025, securing 38% share, driven by innovation in 3D visualization.
• Japan reached USD 0.5 Billion in 2025, capturing 31% share, due to strong adoption of high-tech surgical imaging.
• China accounted for USD 0.3 Billion in 2025, holding 19% share, supported by increasing hospital infrastructure upgrades.

By Application

Hospitals

Hospitals represent the largest application area for minimally invasive surgical devices, with over 70% of procedures conducted in hospital settings. Advanced infrastructure, access to skilled surgeons, and availability of robotic-assisted systems drive adoption in this segment. Increasing preference for shorter hospital stays and improved patient outcomes further accelerates demand.

Hospitals accounted for USD 12.5 Billion in 2025, representing 59.8% of the total market. This segment is projected to grow at a CAGR of 6.7% from 2025 to 2034, driven by the growing number of complex surgeries, technological integration, and patient safety improvements.

Top 3 Major Dominant Countries in the Hospitals Segment

• United States led the Hospitals segment with a market size of USD 4.5 Billion in 2025, holding a 36% share and expected to grow at a CAGR of 6.9% due to robotic integration and advanced surgical facilities.
• Germany recorded USD 2.0 Billion in 2025, representing 16% share, supported by high-quality healthcare systems and adoption of laparoscopic devices.
• Japan accounted for USD 1.7 Billion in 2025, holding 14% share, with growth driven by advanced imaging and endoscopic technologies.

Surgical Centers

Surgical centers are rapidly expanding as cost-effective alternatives to hospitals, capturing more than 20% of total minimally invasive procedures. Outpatient surgeries, shorter recovery times, and reduced costs make surgical centers increasingly popular among patients worldwide. Around 55% of new investments in this sector are directed toward minimally invasive technologies.

Surgical Centers were valued at USD 6.0 Billion in 2025, representing 28.7% of the total market. This segment is anticipated to grow at a CAGR of 7.0% from 2025 to 2034, supported by rising outpatient procedures, efficiency improvements, and affordability for patients.

Top 3 Major Dominant Countries in the Surgical Centers Segment

• United States led the Surgical Centers segment with a market size of USD 2.2 Billion in 2025, holding a 36% share and projected to grow at a CAGR of 7.2% due to demand for outpatient robotic procedures.
• India accounted for USD 1.3 Billion in 2025, securing 22% share, driven by cost-effective surgical services and a surge in laparoscopic demand.
• Brazil recorded USD 1.0 Billion in 2025, holding 17% share, supported by rapid expansion of ambulatory surgical centers and affordable device adoption.

Others

The “Others” segment, which includes specialty clinics and research institutions, is witnessing increasing demand for minimally invasive devices. Around 10% of global adoption stems from this category, largely due to diagnostic and therapeutic procedures outside traditional hospitals and surgical centers.

The Others segment accounted for USD 2.4 Billion in 2025, representing 11.5% of the global market. This segment is expected to grow at a CAGR of 5.8% from 2025 to 2034, driven by growing investments in specialty care centers and increased preference for outpatient diagnostics.

Top 3 Major Dominant Countries in the Others Segment

• China led the Others segment with a market size of USD 0.9 Billion in 2025, holding 37% share, with growth supported by specialty endoscopy centers.
• South Korea accounted for USD 0.7 Billion in 2025, representing 29% share, driven by strong investments in outpatient diagnostic facilities.
• Australia registered USD 0.5 Billion in 2025, holding 21% share, due to increasing demand in private surgical clinics and research-based adoption.

Minimally Invasive Surgical Devices Market Regional Outlook

The global minimally invasive surgical devices market was valued at USD 19.59 Billion in 2024 and is projected to reach USD 20.9 Billion in 2025, expanding further to USD 37.3 Billion by 2034 at a CAGR of 6.65%. Regionally, North America accounts for 35% of the market share, Europe holds 25%, Asia-Pacific leads with 30%, and the Middle East & Africa contributes 10%, together making up 100% of the global market.

North America

North America dominates the market due to advanced healthcare infrastructure, high adoption of robotic-assisted surgeries, and increasing demand for minimally invasive techniques. Over 65% of hospitals in the region use robotic platforms, while 58% of surgical centers have adopted laparoscopic technologies, driving strong growth across the United States and Canada.

North America held the largest share in the market, accounting for USD 7.3 Billion in 2025, representing 35% of the total market. This segment is expected to grow at a CAGR of 6.8% from 2025 to 2034, driven by technological innovation, rising surgical volumes, and favorable reimbursement policies.

North America - Major Dominant Countries in the Minimally Invasive Surgical Devices Market

• United States led the North America market with USD 5.2 Billion in 2025, holding a 71% share and projected to expand at a CAGR of 6.9% due to advanced robotic adoption and patient demand.
• Canada recorded USD 1.4 Billion in 2025, securing 19% share, supported by increased healthcare spending and improved access to minimally invasive surgeries.
• Mexico accounted for USD 0.7 Billion in 2025, representing 10% share, driven by growing surgical tourism and hospital expansions.

Europe

Europe maintains a strong position supported by innovation in laparoscopic and endoscopic devices, with nearly 55% of hospitals adopting minimally invasive procedures. Around 48% of healthcare facilities have invested in advanced visualization systems, while 40% of patients prefer non-invasive methods for treatment, strengthening the region’s overall adoption rates.

Europe held USD 5.2 Billion in 2025, representing 25% of the global market. This segment is forecasted to grow at a CAGR of 6.3% from 2025 to 2034, driven by advancements in imaging, government funding, and expansion of surgical training programs.

Europe - Major Dominant Countries in the Minimally Invasive Surgical Devices Market

• Germany led the Europe market with USD 1.7 Billion in 2025, holding a 33% share and expected to grow at a CAGR of 6.4% due to technological innovation and surgical expertise.
• France recorded USD 1.4 Billion in 2025, representing 27% share, supported by healthcare modernization and high laparoscopic adoption.
• United Kingdom accounted for USD 1.1 Billion in 2025, securing 21% share, driven by patient demand for minimally invasive procedures.

Asia-Pacific

Asia-Pacific is emerging as the fastest-growing region, with nearly 62% of hospitals adopting endoscopic and laparoscopic techniques. Demand is rising as 54% of patients in urban areas prefer less invasive procedures, while government healthcare initiatives contribute to improved surgical access across China, Japan, and India.

Asia-Pacific accounted for USD 6.3 Billion in 2025, representing 30% of the market. This segment is expected to grow at a CAGR of 7.4% from 2025 to 2034, supported by large patient pools, expanding medical tourism, and rapid adoption of advanced surgical technologies.

Asia-Pacific - Major Dominant Countries in the Minimally Invasive Surgical Devices Market

• China led the Asia-Pacific market with USD 2.4 Billion in 2025, holding a 38% share and projected to grow at a CAGR of 7.6% due to high surgical volumes and expanding healthcare access.
• Japan recorded USD 2.0 Billion in 2025, representing 32% share, supported by strong endoscopy adoption and advanced imaging technologies.
• India accounted for USD 1.3 Billion in 2025, securing 21% share, driven by growing demand for laparoscopic and robotic-assisted surgeries.

Middle East & Africa

The Middle East & Africa market is growing steadily, supported by rising investments in healthcare infrastructure and a 45% increase in minimally invasive procedure adoption across private hospitals. Around 33% of facilities in the region have incorporated laparoscopic devices, while robotic-assisted systems are gradually gaining momentum.

Middle East & Africa contributed USD 2.1 Billion in 2025, representing 10% of the global market. This region is projected to grow at a CAGR of 5.5% from 2025 to 2034, driven by healthcare modernization, expanding private hospital chains, and rising medical tourism.

Middle East & Africa - Major Dominant Countries in the Minimally Invasive Surgical Devices Market

• United Arab Emirates led with USD 0.8 Billion in 2025, holding 38% share, supported by advanced hospital infrastructure and surgical tourism growth.
• Saudi Arabia recorded USD 0.7 Billion in 2025, representing 33% share, driven by government healthcare investments and adoption of robotic technologies.
• South Africa accounted for USD 0.4 Billion in 2025, securing 19% share, supported by rising demand for endoscopic and laparoscopic procedures.

List of Key Minimally Invasive Surgical Devices Market Companies Profiled

Investment Analysis and Opportunities in Minimally Invasive Surgical Devices Market

Investments in minimally invasive surgical devices are accelerating as healthcare systems prioritize cost reduction and patient safety. More than 60% of hospitals globally allocate significant budgets to robotic-assisted and laparoscopic technologies. Around 48% of private healthcare providers are focusing on upgrading visualization systems, while 55% of investors consider outpatient surgical centers as a major growth driver. Nearly 42% of emerging economies are expanding healthcare infrastructure to support minimally invasive surgeries, creating strong opportunities for device manufacturers. With 65% of patients preferring less invasive options, companies investing in training programs and new device innovations are positioned to capture long-term growth opportunities in this evolving sector.

New Products Development

New product development in minimally invasive surgical devices is accelerating with continuous innovation in robotic systems, electrosurgery, and endoscopic tools. Around 40% of companies are focusing on smart visualization platforms with real-time imaging integration. Nearly 35% of R&D investments are being directed toward handheld laparoscopic instruments with improved precision and ergonomic design. More than 50% of leading players are expanding their portfolios with AI-assisted robotic solutions to enhance surgical accuracy. Additionally, 47% of global manufacturers are developing energy-efficient electrosurgical devices, while 30% are prioritizing cost-effective solutions for emerging markets. This wave of product innovation is reshaping competitive dynamics and strengthening growth potential in the market.

Recent Developments

• Medtronic PLC: In 2024, Medtronic introduced next-generation laparoscopic instruments with enhanced ergonomic designs. Over 45% of surgeons reported improved handling efficiency, while 38% noted reduced operating time, strengthening adoption across global hospitals.
• Intuitive Surgical Inc: Intuitive expanded its robotic-assisted platform with AI-powered imaging integration. Nearly 55% of hospitals adopting the upgrade observed a 40% improvement in surgical precision, while 33% reported fewer complications during complex procedures.
• Olympus Corp: Olympus launched advanced endoscopy systems with 4K visualization technology. Around 52% of physicians experienced better diagnostic accuracy, and 41% confirmed reduced error rates in procedures such as gastroenterology and pulmonology.
• Stryker Corporation: Stryker released minimally invasive orthopedic surgical tools in 2024. More than 48% of orthopedic specialists cited faster recovery times for patients, and 37% reported improved accuracy in joint replacement surgeries.
• Becton Dickinson and Co: BD expanded its electrosurgery product line with energy-efficient devices. Approximately 50% of clinics adopting the innovation observed lower energy usage, and 42% highlighted safer outcomes in tissue cutting and coagulation procedures.

Report Coverage

The report on the minimally invasive surgical devices market provides comprehensive insights into market size, segmentation, regional outlook, competitive landscape, and emerging opportunities. Covering both type and application segments, it highlights that endoscopes account for 24.4% of the global market in 2025, while robotic-assisted surgical systems hold 21.5% with the fastest growth potential. Applications reveal hospitals dominate with nearly 59.8% share, followed by surgical centers with 28.7% and others with 11.5%. Regionally, Asia-Pacific leads in growth momentum with 30% share, while North America holds 35% of the market due to advanced healthcare infrastructure and higher adoption rates.

The coverage further examines competitive dynamics, listing key players such as Medtronic, Intuitive Surgical, Olympus, Stryker, and Becton Dickinson, with Medtronic holding 18% share and Intuitive capturing 16%. The report analyzes opportunities, showing that 55% of investors are focusing on outpatient surgical centers, while 42% of emerging economies are expanding infrastructure to adopt these devices. It also details recent innovations, such as 4K visualization and AI-assisted robotic integration, with over 50% of surgeons reporting improved outcomes. By assessing trends, opportunities, restraints, and challenges, the coverage ensures a data-driven understanding of the market, providing stakeholders with actionable insights for strategic decision-making.